Natural Biologics
Natural Biologics, headquartered in the United States, is a leading player in the biotechnology industry, specialising in the development of innovative biologic therapies. Founded in 2010, the company has made significant strides in advancing regenerative medicine, focusing on harnessing the power of natural biological processes to create effective treatments. With a strong presence across North America and Europe, Natural Biologics offers a range of core products, including advanced cellular therapies and tissue regeneration solutions. What sets them apart is their commitment to utilising cutting-edge research and technology to ensure the highest quality and efficacy in their offerings. Recognised for their contributions to the field, Natural Biologics has established a solid market position, earning accolades for their pioneering work in biologic treatments. Their dedication to innovation continues to drive their success and influence in the biotechnology landscape.
DitchCarbon Score
How does Natural Biologics's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Natural Biologics's score of 20 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Natural Biologics's reported carbon emissions
Natural Biologics, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current impact on carbon emissions or their strategic approach to climate change. However, the absence of data may indicate an opportunity for the company to enhance transparency and set measurable targets in line with industry standards. As the global focus on sustainability intensifies, Natural Biologics may consider establishing clear commitments to reduce their carbon footprint and contribute positively to climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Natural Biologics is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
